Primary Job Title Non Executive Director Primary Organization Sentinel Oncology
Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Dan has over 15 years’ experience in the contract research and biotechnology industries. He has been involved in 'hit to lead' discovery and the investigation of new technologies in the areas of automation, high-throughput catalysis, pharmaceutical solid form and lead generation.
Dan was co-founder of Pharmorphix, a specialist CRO in
the area of solid form, which grew market share rapidly and was subsequently acquired by Sigma Aldrich in 2006.
Following the sale of Pharmorphix he founded Hypoxium, a client focused CRO providing pre-clinical oncology research which grew its revenue at over 75% each year.
He was appointed COO of Horizon Discovery following its acquisition in 2010.
